Maria Cano

2.4k citations

54 papers · 1.7k indexed · 1 hit paper · h-index 22

Impact in

Health top 1%
- Vaccine Coverage and Hesitancy
Epidemiology top 2%
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
- Influenza Virus Research Studies

Papers in

Toxicology 10
- Pharmacovigilance and Adverse Drug Reactions 10
Health 18
- Vaccine Coverage and Hesitancy 18

Co-authors: Pedro L. Moro Paige Lewis Tom T. Shimabukuro Lauri E. Markowitz Carmen S. Ng Julianne Gee Shannon Stokley David Yankey
Journals: Vaccine (24 papers)MMWR Morbidity and Mortality Weekly Report (5 papers)Open Forum Infectious Diseases (3 papers)Clinical Infectious Diseases (2 papers)Human Vaccines & Immunotherapeutics (2 papers)
Partner nations: United States Uganda Thailand

In The Last Decade

Maria Cano

53 papers receiving 1.7k citations

Hit Papers

align trajectories log scale

Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States. 2014 · 447 citations

Peers

Countries citing papers authored by Maria Cano

Since Specialization

Citations

This map shows the geographic impact of Maria Cano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Cano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Cano more than expected).

Fields of papers citing papers by Maria Cano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Cano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Cano. The network helps show where Maria Cano may publish in the future.

Co-authors

The 25 scholars most cited alongside Maria Cano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maria Cano Line = papers co-authored together Maria Cano links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Safety surveillance of meningococcal group B vaccine (Bexsero®), Vaccine Adverse Event Reporting System, 2015–2018 Vaccine ·Silvia Pérez-Vilar, Graça M. Dores, Paige Marquez, Carmen S. Ng, Maria Cano, Katsuro Yahiro, Lucia Lee, John R. Su, Jonathan Duffy	2021	6
2	Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990–2018 Vaccine ·John R. Su, Michael M. McNeil, Kerry J. Welsh, Paige Marquez, Carmen S. Ng, Ming Yan, Maria Cano	2021	113
3	Monitoring the safety of high-dose, trivalent inactivated influenza vaccine in the vaccine adverse event reporting system (VAERS), 2011 – 2019 Vaccine ·Pedro L. Moro, Emily Jane Woo, Paige Marquez, Maria Cano	2020	13
4	Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged ≥65 years, Vaccine Adverse Event reporting System (VAERS), United States, September 2010–December 2018 Vaccine ·Penina Haber, Pedro L. Moro, Carmen S. Ng, Graça M. Dores, Silvia Pérez-Vilar, Paige Marquez, Maria Cano	2019	4
5	Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999–2017 Vaccine ·John R. Su, Penina Haber, Carmen S. Ng, Paige Marquez, Graça M. Dores, Silvia Pérez-Vilar, Maria Cano	2019	32
6	Adverse events following adenovirus type 4 and type 7 vaccine, live, oral in the Vaccine Adverse Event Reporting System (VAERS), United States, October 2011–July 2018 Vaccine ·Michael M. McNeil, Iwona Paradowska‐Stankiewicz, Elaine R. Miller, Paige Marquez, 饶从亮, Limone Collins, Maria Cano	2019	19
7	Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007–2017 Vaccine ·Pedro L. Moro, Jorge E. Araña, Paige Marquez, Carmen S. Ng, Christian Agustin Tapa, Beth F. Hibbs, Maria Cano	2019	9
8	Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009–2015 Vaccine ·Jorge E. Araña, Theresa Harrington, Maria Cano, Paige Lewis, Adamma Mba‐Jonas, Rongxia Li, Brock Stewart, Lauri E. Markowitz, Tom T. Shimabukuro	2018	51
9	Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005–2015 Vaccine ·Penina Haber, Pedro L. Moro, Carmen S. Ng, Регина Петровна Костровская, Beth F. Hibbs, Sarah Schillie, Noele P. Nelson, Rongxia Li, Brock Stewart, Maria Cano	2017	11
10	Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System Vaccine ·Emily Jane Woo, Pedro L. Moro, Maria Cano, Christopher Jankosky	2017	21
11	Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010–2015 Vaccine ·Tanya R. Myers, Michael M. McNeil, Carmen S. Ng, Rongxia Li, Регина Петровна Костровская, Maria Cano	2017	22
12	Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015 PLoS neglected tropical diseases ·Pedro L. Moro, Emily Jane Woo, Abdelmadjid Chouabi, Paige Lewis, Brett W. Petersen, Maria Cano	2016	16
13	Post-licensure surveillance of 13-valent pneumococcal conjugate vaccine (PCV13) in adults aged ⩾19years old in the United States, Vaccine Adverse Event Reporting System (VAERS), June 1, 2012–December 31, 2015 Vaccine ·Penina Haber, Jorge E. Araña, Tamara Pilishvili, Paige Lewis, Pedro L. Moro, Maria Cano	2016	10
14	Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System, July 2010–May 2016 Drug Safety ·Pedro L. Moro, Jane Baumblatt, Paige Lewis, Janet D. Cragan, Naomi K. Tepper, Maria Cano	2016	30
15	Deaths Reported to the Vaccine Adverse Event Reporting System, United States, 1997–2013 Clinical Infectious Diseases ·Pedro L. Moro, Jorge E. Araña, Maria Cano, Paige Lewis, Tom T. Shimabukuro	2015	27
16	Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States. PubMed ·Shannon Stokley, Jenny Jeyarajah, David Yankey, Maria Cano, Julianne Gee, NADİDE ERDÖNMEZ, C. Robinette Curtis, Lauri E. Markowitz Hit paper breakdown →	2014	447
17	Ischemic cardiac events and other adverse events following ACAM2000® smallpox vaccine in the Vaccine Adverse Event Reporting System Vaccine ·Michael M. McNeil, Maria Cano, Elaine R. Miller, Brett W. Petersen, Renata J.M. Engler, Marthe Bryant-Genevier	2014	16
18	Unintentional transfer of vaccinia virus associated with smallpox vaccines Human Vaccines & Immunotherapeutics ·Danielle M. Tack, Kevin L. Karem, Jay R Montgomery, Limone Collins, Marthe Bryant-Genevier, Rosemary Tiernan, Maria Cano, Paige Lewis, Renata J.M. Engler, Inger K. Damon, Mary G. Reynolds	2013	18
19	Health Status of Visitors and Temporary Residents, United States Emerging infectious diseases ·Emad Yanni, Nina Marano, William M. Stauffer, Elizabeth D. Barnett, Maria Cano, Martín S. Cetron	2009	4
20	Candidemia in pediatric outpatients receiving home total parenteral nutrition Medical Mycology ·Maria Cano, Joseph F. Perz, Allen S. Craig, Robert K. Pelant, G. Marshall Lyon, Mary E. Brandt, T. J. Lott, Brent A. Lasker, Fred F. Barrett, Michael M. McNeil, William Schaffner, Rana Hajjeh	2004	13

About Maria Cano

Maria Cano is a scholar working on Toxicology, Health, Microbiology, Virology and Epidemiology, having authored 54 papers that have together received 1.7k indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (18 papers), Influenza Virus Research Studies (17 papers), SARS-CoV-2 and COVID-19 Research (12 papers), Bacterial Infections and Vaccines (10 papers), Pharmacovigilance and Adverse Drug Reactions (10 papers), Heparin-Induced Thrombocytopenia and Thrombosis (8 papers), Peripheral Neuropathies and Disorders (6 papers) and Hepatitis B Virus Studies (6 papers). The work is most often cited by research in Health (473 citations), Epidemiology (1.1k citations), Infectious Diseases (482 citations), Toxicology (76 citations) and Microbiology (108 citations). Maria Cano has collaborated with scholars based in United States, Uganda and Thailand. Frequent co-authors include Pedro L. Moro, Paige Lewis, Tom T. Shimabukuro, Lauri E. Markowitz, Carmen S. Ng, Julianne Gee, Shannon Stokley, David Yankey, C. Robinette Curtis and Jenny Jeyarajah. Their work appears in journals such as Vaccine, MMWR Morbidity and Mortality Weekly Report, Open Forum Infectious Diseases, Clinical Infectious Diseases and Human Vaccines & Immunotherapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact